Chimeric antigen receptor-T (CAR-T) cell-derived exosomes (CAR-T-Exo) contain tumor-targeted CAR and cytotoxic particles (granzyme B [GZMB] and perforin [PRF]), which can be used in the treatment of tumors and are considered potential carriers of paclitaxel (268). Here, GZMB is linked to neoplasm.